Meridian Wealth Advisors’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Meridian Wealth Advisors’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-100,000	Closed	-$3.5M	–	181
2024 Q1	$3.5M	Sell	100,000 -22,315	-18%	-$814K	0.66%	42
2023 Q4	$4.65M	Hold	122,315	–	–	1.02%	27
2023 Q3	$2.24M	Hold	122,315	–	–	0.56%	46
2023 Q2	$3.18M	Hold	122,315	–	–	0.77%	36
2023 Q1	$2.31M	Hold	122,315	–	–	0.58%	46
2022 Q4	$3.01M	Hold	122,315	–	–	0.78%	34
2022 Q3	$2.2M	Hold	122,315	–	–	0.62%	39
2022 Q2	$1.39M	Hold	122,315	–	–	0.37%	64
2022 Q1	$2.73M	Hold	122,315	–	–	0.63%	42
2021 Q4	$5.34M	Hold	122,315	–	–	1.3%	18
2021 Q3	$4.07M	Hold	122,315	–	–	1.13%	18
2021 Q2	$3.37M	Buy	+122,315	New	+$2.55M	0.95%	20

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Meridian Wealth Advisors's INBX Position: Q2 2024 in Review

Meridian Wealth Advisors sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 100,000 shares — an estimated $3.5M sold.

Meridian Wealth Advisors first reported a position in INBX in Q2 2021 and held it in 12 quarters. The position peaked at $5.34M in Q4 2021. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Meridian Wealth Advisors reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Meridian Wealth Advisors sold 100,000 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $3.5M.
Meridian Wealth Advisors first reported a position in Inhibrx, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
Meridian Wealth Advisors's Inhibrx, Inc. Common Stock position peaked at $5.34M in Q4 2021.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Meridian Wealth Advisors's 13F filing for Q2 2024, filed 2 Aug 2024.